PHKA1 and non-small cell lung carcinoma: Four days after transfection was used to test cell viability, and the results indicated that up‐regulating PHKA1‐AS1 improved NSCLC cell viability, whereas the opposite result was obtained after down‐regulating PHKA1‐AS1 (Figure 1C, D).